
Sens. Mike Lee, R-Utah, and Amy Klobuchar, D-Minn., the top lawmakers in the upper chamber’s antitrust committee, on Tuesday raised concerns over Albertsons’ merger with Kroger, questioning whether the companies can fulfill commitments to lower prices and increase employee wages, reports The Hill.
“The companies assure us that this is the merger that will make everything better,” Lee, ranking member of the Senate Judiciary Subcommittee on Competition Policy, Antitrust and Consumer Rights, said during a hearing on the planned $25 billion merger.
Read more: Kroger, Albertsons CEOs Face US Congressional Panel On Merger
“They have announced commitments to spend $500 million to lower prices, $1.3 billion to update their stores and a billion dollars to increase employee wages. Of course, they haven’t explained how we can be sure that these commitments will actually be fulfilled.”
Klobuchar, chair of the committee, said she worried the deal would mean a loss of competition in groceries and, potentially, higher costs at a time when inflation is already high.
“That’s why you’ve heard concern across the country about this transaction,” she said.
The deal will be reviewed by the Federal Trade Commission to ensure it is legal under antitrust law.
Stores under the Albertsons umbrella include Balducci’s, Haggen, Kings, Safeway, Star Market, Tom Thumb, United Supermarkets and Vons, among others. Kroger owns Baker’s, Dillons, Fred Meyer, King Soopers, Mariano’s, Pick’n Save and Ralphs.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas